...
首页> 外文期刊>Journal of Clinical Microbiology >Reproducibility of an Indirect Immunofluorescent-Antibody Technique for Capsular Serotyping of Klebsiella pneumoniae
【24h】

Reproducibility of an Indirect Immunofluorescent-Antibody Technique for Capsular Serotyping of Klebsiella pneumoniae

机译:肺炎克雷伯氏菌荚膜血清分型的间接免疫荧光抗体技术的重现性

获取原文
           

摘要

Reproducibility of capsular serotypes of 55 consecutive clinical isolates of Klebsiella pneumoniae was evaluated by an indirect immunofluorescent-antibody technique previously described by Riser et al. (J. Clin. Pathol. >29: 296-304, 1976) Five colonies per specimen were examined for colony-to-colony variation, day-to-day variation, and reader-to-reader variation. Seventy-two reference strains were tested with each of 18 pools and 72 specific antisera prior to the clinical specimens to determine antiserum specificity and cross-reaction patterns. Lot-to-lot variation was examined with the reference strains. There was minimal lot-to-lot variation among the antisera tested. Ten antiserum pools required supplementation with individual antisera. The patterns of supplementation may vary from lot to lot. Colony-to-colony variation in intensity of immunofluorescence occurred, but there was no variation in serotype. These findings differ from previously reported colonial variation which occurred when API 20E biotypes were determined for individual colonies of K. pneumoniae directly from clinical specimens. Eighteen percent of clinical isolates studied gave cross-reactions when tested with the indicated specific antiserum. All but one of the cross-reactions were resolved with further dilutions. Day-to-day and reader-to-reader variations were minimal. The immunofluorescent-antibody technique is a reliable and reproducible method for capsular serotype determination. Capsular serotypes are less variable than API biotypes since colony-to-colony variation of serotype does not occur.
机译:通过以前由Riser等人描述的间接免疫荧光抗体技术评估了55例肺炎克雷伯菌的连续临床分离株荚膜血清型的可重复性。 (J. Clin。Pathol。> 29:,296-304,1976年)检查每个标本五个菌落的菌落与菌落变异,每日变异和读者与读者之间的变异。在临床标本之前,对18个库和72个特异性抗血清分别测试了72个参考菌株,以确定抗血清特异性和交叉反应模式。用参考菌株检查批间差异。在测试的抗血清之间,批次间的差异最小。十个抗血清库需要补充单个抗血清。补充方式可能因批次而异。免疫荧光强度发生菌落到菌落的变化,但血清型没有变化。这些发现与先前报道的殖民地变异不同,后者是针对 K的单个菌落确定API 20E生物型时发生的。直接来自临床标本的肺炎。用指定的特定抗血清进行测试时,有18%的临床分离株产生交叉反应。除进一步的交叉反应外,所有交叉反应均被进一步稀释。日常变化和读者之间的变化很小。免疫荧光抗体技术是确定荚膜血清型的可靠且可重复的方法。胶囊型血清型的变异性不如API生物型,因为不会发生菌落到菌落的血清型变异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号